L-carnitine has been a fixture of Japanese diet and metabolism products since the early 2000s, sold in tablets, drinks and jelly formats. Brands abroad ask for it by name, sometimes expecting stronger results than the research actually supports.
This guide covers what meta-analyses of controlled trials show for weight and fat mass, how Japan’s Foods with Function Claims system has used L-carnitine, its regulatory history as a food ingredient, and how to formulate it.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning an L-carnitine product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
Meta-analyses of randomised controlled trials find a modest reduction in body weight with L-carnitine, mainly in adults with overweight or obesity, but no difference in waist circumference or body fat percentage, and an effect that shrinks the longer people take it.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| Systematic review and meta-analysis, Clinical Nutrition ESPEN 2020;37:9–23 (PMID 32359762) | 37 randomised controlled trials, 2,292 participants, dose-response analysis | Body weight decreased by a weighted mean of 1.21 kg, BMI by 0.24 kg/m², fat mass by 2.08 kg; no significant effect on waist circumference or body fat percentage; in high-quality trials only, the effect was confirmed for body weight alone; dose-response modelling for body weight suggested around 2,000 mg per day gave the maximum effect, with no such association for BMI, waist or body fat percentage; described as a modest effect, especially in adults with overweight/obesity |
| Systematic review and meta-analysis, Obesity Reviews 2016;17(10):970–976 (PMID 27335245) | 9 randomised controlled trials, 911 adults | Carnitine groups lost significantly more weight (mean difference 1.33 kg) and showed a greater BMI reduction (0.47 kg/m²) than control groups; the size of the weight loss decreased significantly the longer supplementation continued |
Caveats worth keeping in view:
- The effect size is modest across both meta-analyses, roughly one to two kilograms on average, not a dramatic change, and results vary by individual trial.
- Not every body measure moved. Waist circumference and body fat percentage did not differ from control in the 2020 meta-analysis, and only the body-weight result held in the high-quality trials.
- The effect fades over time. The 2016 meta-analysis found that the extra weight loss became smaller the longer carnitine was taken.
- Most benefit was seen in adults already carrying excess weight, not in lean or normal-weight populations, and trial populations, doses and durations varied considerably between the studies pooled.
- Neither meta-analysis substitutes for diet and activity. The trials tested carnitine as an addition to, not a replacement for, other weight-management measures.
Checked against the published abstracts on 13 October 2026.
What Japanese products say
Japan has allowed L-carnitine in foods since 2002, provided no medicinal claim is made, with a government request to guard against excessive intake, and L-carnitine has since been notified under Japan’s Foods with Function Claims system.
A Ministry of Health, Labour and Welfare notice dated 15 November 2002 added L-carnitine to the list of substances not judged to be medicines unless medicinal effects are claimed, and a notice of 25 December 2002 set how it is handled under food sanitation law. That opened the door to the tablets, drinks and jelly-format products that followed. A further ministry notice of 5 November 2004 asks businesses using L-carnitine to take care that it is not consumed to excess and to give consumers appropriate information, noting that the United States has assessed an acceptable daily intake of 20 mg/kg body weight per day and that Switzerland sets 1,000 mg per day as a condition of intake. Under the Foods with Function Claims system, at least one notified product has used wording describing L-carnitine as supporting fat burning in energy metabolism during daily physical activity above a stated intensity threshold, taken as a single dose, based on the notifying company’s own submitted evidence.
Three points for a brand abroad:
- Plan the daily amount with the 2004 notice in mind. A daily amount above the levels cited in that notice, such as the 2,000 mg modelled in the 2020 meta-analysis, needs a clear safety rationale and consumer information.
- A Foods with Function Claims notification is specific to the notifying company’s product, dose and evidence package, not a general endorsement of L-carnitine at any dose or in any formula.
- The Japanese wording ties the claimed effect to a defined level of physical activity, not to fat loss on its own; copying the wording into a market without matching evidence goes beyond what either the notification or the independent meta-analyses support.
💬 Need an evidence summary for your regulatory adviser that separates the independent meta-analyses from Japan’s Foods with Function Claims wording? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe L-carnitine by what the meta-analyses actually measured, in the population studied, not as a guaranteed fat-loss result.
| Safer wording | Wording to avoid |
|---|---|
| ”Studied for body weight and fat mass alongside diet and activity" | "Burns fat” or “melts weight” without qualification |
| ”Amount per serving matched to the studied dose range” | Doses far outside the studied range presented as more effective |
| ”May support energy metabolism during physical activity” | Disease names (obesity as a medical condition), or “treats” any condition |
How L-carnitine is formulated
L-carnitine is water-soluble and available in several salt forms, so the main formulation decisions are about form, taste and dose rather than stability.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Tablet or capsule | Precise dosing, familiar format | Multiple tablets often needed to reach gram-level doses |
| Drink or jelly | A common Japanese format for diet-support products | Taste can be sharp at higher concentrations; needs masking |
| Powder (stick or scoop) | Flexible dosing, often combined with other sports or weight ingredients | Requires accurate measuring by the consumer |
Decisions that shape the specification:
- Salt form. L-carnitine is commonly supplied as L-carnitine L-tartrate or other salts; confirm which form your target market’s studies and regulations reference.
- Amount per serving. The 2020 meta-analysis pointed to around 2,000 mg per day for the maximum modelled effect on body weight only. Weigh that against the 2004 ministry notice on avoiding excessive intake, and confirm your target dose against the population and duration you intend to describe.
- Companion ingredients. L-carnitine is often combined with other metabolism or sports ingredients in diet-support formulas. Every companion ingredient needs its own check against Japanese food law.
- Your market’s status for L-carnitine. Its status as a food ingredient and any claim restrictions differ between countries. Confirm it before you commit to a formula.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
L-carnitine itself has been usable in Japanese foods since 2002, provided no medicinal claim is made. Companion ingredients in a weight-management formula are where problems more often appear. See the Japan-made supplement OEM page, and compare with our MCT oil and green tea catechin guides.
Before you ask for a quotation
A factory can quote accurately once the amount, the form, the companions and the packaging are fixed.
- L-carnitine amount per serving and salt form
- Dosage form, and flavour if drink or jelly
- Companion ingredients and their amounts
- Packaging
- Countries you will sell in, and L-carnitine’s status and claim rules there
- First order and annual volume
💬 Ready to design a Japan-made L-carnitine product? Send us the concept — amount, form, companion ingredients and the countries you will sell in.
Frequently asked questions
1. Does L-carnitine actually help with weight loss?
A 2020 meta-analysis of 37 randomised trials found a modest average reduction in body weight (1.21 kg), BMI and fat mass, mostly in adults with overweight or obesity, but no difference in waist circumference or body fat percentage. A 2016 meta-analysis found the effect became smaller over time. It is a modest effect alongside diet and activity, not a guaranteed or dramatic result.
2. What dose was studied?
Dose-response modelling in the 2020 meta-analysis suggested around 2,000 mg per day gave the largest modelled effect on body weight, with no such link for BMI, waist or body fat percentage. Individual trials used a range of doses and durations, and a 2004 Japanese ministry notice asks businesses to guard against excessive intake.
3. Can a Japanese factory make an L-carnitine product?
Yes. A Ministry of Health, Labour and Welfare notice of November 2002 made L-carnitine usable in foods as long as no medicinal effect is claimed, and a 2004 notice asks businesses to avoid excessive intake and inform consumers.
4. Has L-carnitine been used in Japan’s Foods with Function Claims system?
At least one notified product has described L-carnitine as supporting fat burning in energy metabolism during physical activity above a stated intensity, taken as a single dose. That notification applies to the specific product and evidence submitted, not to L-carnitine generally.
5. What should I decide before asking for a quotation?
The salt form, the amount per serving, the dosage form, any companion ingredients, and the countries you plan to sell in, since claim rules for weight-related wording vary by market.
Sources: “Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis”, Clinical Nutrition ESPEN 2020;37:9–23, PMID 32359762; “The effect of (L-)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials”, Obesity Reviews 2016;17(10):970–976, PMID 27335245; Ministry of Health, Labour and Welfare notices Iyakuhatsu No. 1115003 (15 November 2002) and Shokukihatsu No. 1225001 (25 December 2002), as cited in the Food Safety Commission of Japan draft risk assessment on L-carnitine (2015); Ministry of Health, Labour and Welfare notice Shokuankihatsu No. 1105001 (5 November 2004), note 2; Consumer Affairs Agency, Foods with Function Claims notification database (L-carnitine, single-dose fat-burning-in-activity function). Checked on 13 October 2026.